Corporate Governance Announcements and Circulars Presentations Financial Report Investor Inquiry

List of Directors and Their Roles and Functions

Terms of Reference of the Audit Committee

Terms of Reference of the Compensation Committee

Terms of Reference of the Nomination Committee

Procedures for Shareholders to Propose a Person for Election as a Director of the Company

Shareholders' Communication Policy

Board of Directors

Mr. Ni Xin

Executive Director

Ms. Zhai Jing

Executive Director

Dr. David Guowei Wang

Non-executive Director

Mr. Yu Tieming

Non-executive Director

Dr. Xu Qing

Independent Non-executive Director

Mr. Chen Wen

Independent Non-executive Director

Ms. Zheng Jingjing

Independent Non-executive Director
Audit Committee

Ms. Zheng Jingjing

Chairman

Mr. Yu Tieming

member

Dr. Xu Qing

Member
Compensation Committee

Dr. Xu Qing

Chairman

Dr. David Guowei Wang

Member

Mr. Chen Wen

member
Nomination Committee

Mr. Ni Xin

Chairman

Dr. Xu Qing

member

Ms. Zheng Jingjing

member

13

2026.02

NEXT DAY DISCLOSURE RETURN

12

2026.02

NEXT DAY DISCLOSURE RETURN

12

2026.02

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2026

11

2026.02

NEXT DAY DISCLOSURE RETURN

10

2026.02

NEXT DAY DISCLOSURE RETURN

10

2026.02

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2026

09

2026.02

NEXT DAY DISCLOSURE RETURN

09

2026.02

VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE FIRST SUBJECT DOSING IN PHASE II CLINICAL TRIAL OF EDP167

06

2026.02

NEXT DAY DISCLOSURE RETURN

06

2026.02

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2025

Investor Inquiry

Edding Genor Group Holdings Limited

Room 406, Building 1, No. 36 Doukou Road, Hengqin, Zhuhai,China

Room 406, Building 1, No. 36 Doukou Road, Hengqin, Zhuhai,China

IR@eddingpharm.com

IR@eddingpharm.com